![Daniel C. Montano](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel C. Montano
Algemeen Directeur bij Phage Biotechnology Corp.
Actieve functies van Daniel C. Montano
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Phage Biotechnology Corp.
![]() Phage Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Phage Biotechnology Corp. manufactures protein pharmaceuticals including pegylated human growth hormone, pegylated G-CSF, pegylated interferon alpha, beta interferon, and single-chain antibodies. It also develops biopharmaceuticals whose patents expire. The company was founded in 1998 and is headquartered in Las Vegas, NV. | Algemeen Directeur | - | - |
Voorzitter | 01-01-1998 | - | |
Oprichter | 19-02-2010 | - | |
President | 01-01-1998 | - | |
Cardio Phage International, Inc. | Directeur/Bestuurslid | 01-01-1998 | - |
Zhittya Genesis Medicine, Inc.
![]() Zhittya Genesis Medicine, Inc. BiotechnologyHealth Technology Zhittya Genesis Medicine, Inc. operates as a biopharmaceutical company. It develops a biological drug which triggers angiogenesis and neurogenesis. The company was founded by Daniel Montano in 2014 and is headquartered in Las Vegas, NV. | Algemeen Directeur | - | - |
Voorzitter | - | - | |
Oprichter | - | - |
Loopbaan van Daniel C. Montano
Eerdere bekende functies van Daniel C. Montano
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Venturis Therapeutics, Inc.
![]() Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | Algemeen Directeur | 01-03-1998 | 16-09-2014 |
Voorzitter | 01-03-1998 | 16-09-2014 | |
Oprichter | 01-03-1998 | 16-09-2014 | |
President | 01-03-1998 | 16-09-2014 | |
HELEN OF TROY LIMITED | Directeur/Bestuurslid | 01-01-1981 | 01-01-2004 |
Opleiding van Daniel C. Montano
University of Southern California | Masters Business Admin |
California State University-Los Angeles | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Bermuda | 2 |
Bahama's | 2 |
Operationeel
Chief Executive Officer | 3 |
Chairman | 3 |
Founder | 3 |
Sectoraal
Consumer Services | 3 |
Health Technology | 3 |
Consumer Durables | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
HELEN OF TROY LIMITED | Consumer Durables |
Bedrijven in privébezit | 4 |
---|---|
Venturis Therapeutics, Inc.
![]() Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | Commercial Services |
Phage Biotechnology Corp.
![]() Phage Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Phage Biotechnology Corp. manufactures protein pharmaceuticals including pegylated human growth hormone, pegylated G-CSF, pegylated interferon alpha, beta interferon, and single-chain antibodies. It also develops biopharmaceuticals whose patents expire. The company was founded in 1998 and is headquartered in Las Vegas, NV. | Health Technology |
Cardio Phage International, Inc. | |
Zhittya Genesis Medicine, Inc.
![]() Zhittya Genesis Medicine, Inc. BiotechnologyHealth Technology Zhittya Genesis Medicine, Inc. operates as a biopharmaceutical company. It develops a biological drug which triggers angiogenesis and neurogenesis. The company was founded by Daniel Montano in 2014 and is headquartered in Las Vegas, NV. | Health Technology |
- Beurs
- Insiders
- Daniel C. Montano
- Ervaring